• 1 January 1983
    • journal article
    • research article
    • Vol. 28  (5) , 337-340
Abstract
To evaluate the efficacy of cefoxitin, 25 patients with serious pelvic infections admitted to a community hospital were treated with the drug. Twenty-one patients (84%) responded to this therapy. Three of the 4 failures (75%) had a pelvic abscess. Resistant organisms included Staphylococcus aureus, Pseudomonas aeruginosa and enterococci. The adverse reactions encountered were due to localized phlebitis, which occurred in 3 patients (12%). Cefoxitin was successful as a single agent in the treatment of serious soft-tissue pelvic infections.

This publication has 0 references indexed in Scilit: